Libo Pharma Corp. (TPEX:7888)
Taiwan
· Delayed Price · Currency is TWD 45.60
-0.40 (-0.87%)
At close: Mar 9, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.43 billion as of March 9, 2026.
Market Cap
3.43B
Enterprise Value
3.10B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
45.60
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 3.43B, a decrease of -3.29%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.46B | -6.50% |
| Dec 31, 2025 | 3.70B | 4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET Therapeutics | 3.46B |
| Merdury Biopharmaceutical | 3.47B |
| Richmond International Travel & Tours Co.,Ltd | 3.47B |
| Tian Zheng International Precision Machinery | 3.44B |
| Zen Voce | 3.49B |
| CastleNet Technology | 3.49B |
| Celxpert Energy | 3.49B |
| Shine-On BioMedical | 3.43B |